Study linking HRT with dementia risk ‘unhelpful’ Experts point out that no causal relationship between menopausal hormone therapy and dementia has been established.
Why TSH test results can lead to over-testing, over-treatment Lifestyle review is recommended as the first intervention to reduce risk of unnecessary patient harms and resource wastage.
Debate over ‘doctor-approved’ weight loss drugs obtained online Is a GP-reviewed online questionnaire clinically sufficient to safely prescribe injectable medications without a face-to-face consultation? It depends who you ask.
Menopause hormonal treatments to retain PBS listing While GPs have welcomed the news, there are concerns a subsequent price increase will represent further gaps in access to care.
‘Serious implications’ if menopause treatments removed from PBS Experts warn the proposed delisting of medications will not only impose cost-related issues, but potentially affect quality of life.
Outdated information still guides menopause management: Expert Understanding the risks and benefits of various menopausal therapies leads to better outcomes.
‘All GPs should be able to manage menopause’ – but can they? Barriers related to time, education, and the risks of some treatments mean GPs need more support, a menopause expert has said.
Losing everything to find yourself When Trevor first came seeking help for stress and low mood, Dr Hester Wilson sensed there was something deeper going on.
Significant new findings on blood and breast cancers Emerging news could have important implications for GPs and their patients.
What should GPs know about bioidentical hormone therapy? Two experts answer common questions on compounding bioidentical hormone therapy for menopause.